Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

From world-class science to patient-centered care, the 2022 ASCO Genitourinary (GU) Cancers Symposium offered new, innovative findings in the study, diagnosis, and treatment of GU malignancies.   Catch up on key trials in prostate, bladder and kidney cancer, including findings from the PROpel, ARASENS, and BAYOU studies and more.
View all videos

GU Cancers 2022

ASCO Genitourinary Cancers Symposium
17–19 February 2022 | San Francisco, CA

Today is International Women's Day and we are joining the campaign to #InspireInclusion πŸ’™

We'd like to thank all of the incredible women on our editorial board and within this field, who work hard to make a difference πŸ‘©β€βš•οΈπŸ©Ί

#IWD2024

As March is #myelomaawarenessmonth, we wanted to share an update from the 20th International Myeloma Society (IMS) Annual Meeting | The value of #circulating #tumor cells for the staging of patients with #NDMM @BrunoPaiva_UNAV πŸ“£πŸ©Έ

πŸ‘‰ https://www.vjhemonc.com/video/vhnenc6jsa-the-value-of-circulating-tumor-cells-for-the-staging-of-patients-with-ndmm/

#VJHemOnc #MMsm

March is #prostatecancer awareness month and what better time to hear about the latest in prostate cancer therapies?

We have updates from the Phase II #BRCAAway trial, demonstrating the benefits of #combinationtherapy over #sequentialtherapy πŸ”¦πŸŽ₯

πŸ‘‰ https://www.vjoncology.com/video/k0etnzlaq1c-brcaaway-abiraterone-with-olaparib-in-mcrpc-with-hrr-mutations/

Load More

GU Cancers 2022

ASCO Genitourinary Cancers Symposium
17–19 February 2022 | San Francisco, CA
From world-class science to patient-centered care, the 2022 ASCO Genitourinary (GU) Cancers Symposium offered new, innovative findings in the study, diagnosis, and treatment of GU malignancies.   Catch up on key trials in prostate, bladder and kidney cancer, including findings from the PROpel, ARASENS, and BAYOU studies and more.
View all videos

Today is International Women's Day and we are joining the campaign to #InspireInclusion πŸ’™

We'd like to thank all of the incredible women on our editorial board and within this field, who work hard to make a difference πŸ‘©β€βš•οΈπŸ©Ί

#IWD2024

As March is #myelomaawarenessmonth, we wanted to share an update from the 20th International Myeloma Society (IMS) Annual Meeting | The value of #circulating #tumor cells for the staging of patients with #NDMM @BrunoPaiva_UNAV πŸ“£πŸ©Έ

πŸ‘‰ https://www.vjhemonc.com/video/vhnenc6jsa-the-value-of-circulating-tumor-cells-for-the-staging-of-patients-with-ndmm/

#VJHemOnc #MMsm

March is #prostatecancer awareness month and what better time to hear about the latest in prostate cancer therapies?

We have updates from the Phase II #BRCAAway trial, demonstrating the benefits of #combinationtherapy over #sequentialtherapy πŸ”¦πŸŽ₯

πŸ‘‰ https://www.vjoncology.com/video/k0etnzlaq1c-brcaaway-abiraterone-with-olaparib-in-mcrpc-with-hrr-mutations/

Load More